MHC-I genotype and tumor mutational burden predict response to immunotherapy

MLA

Aaron M. Goodman, et al. “MHC-I Genotype and Tumor Mutational Burden Predict Response to Immunotherapy.” Genome Medicine, vol. 12, no. 1, May 2020, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13073-020-00743-4.

APA

Aaron M. Goodman, Andrea Castro, Rachel Marty Pyke, Ryosuke Okamura, Shumei Kato, Paul Riviere, Garrett Frampton, Ethan Sokol, Xinlian Zhang, Edward D. Ball, Hannah Carter, & Razelle Kurzrock. (2020). MHC-I genotype and tumor mutational burden predict response to immunotherapy. Genome Medicine, 12(1), 1–13. https://doi.org/10.1186/s13073-020-00743-4

Chicago

Aaron M. Goodman, Andrea Castro, Rachel Marty Pyke, Ryosuke Okamura, Shumei Kato, Paul Riviere, Garrett Frampton, et al. 2020. “MHC-I Genotype and Tumor Mutational Burden Predict Response to Immunotherapy.” Genome Medicine 12 (1): 1–13. doi:10.1186/s13073-020-00743-4.